InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Explore the detailed record of transactions filed by DANSEY ROGER D, Directeur Médical. Officer active across 2 companies, notably Seagen Inc.. Cumulatively, 19 disclosures have been logged. Total volume traded: €11.8m. The latest transaction was disclosed on 28 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations19 total
€1m17,361 shares@ €61.87088.3% of flow
Common Stock
SEC:0001203311-22-000043:0·
12,000 shares
Common Stock
SEC:0001055726-22-000042:0·
€104,682787 shares@ €133.01410.8% of flow
Common Stock
SEC:0001203311-22-000028:0·
€90,183739 shares@ €122.03351.5% of flow
Common Stock
SEC:0001203311-22-000010·
€90,183739 shares@ €122.03350.7% of flow
Common Stock
SEC:0001203311-22-000010:0·
€465,5223,470 shares@ €134.15617.9% of flow
Common Stock
SEC:0001203311-22-000002·
€465,5223,470 shares@ €134.15613.6% of flow
Common Stock
SEC:0001203311-22-000002:0·
€37,317280 shares@ €133.27660.6% of flow
Common Stock
SEC:0001203311-21-000100·
€37,317280 shares@ €133.27660.3% of flow
Common Stock
SEC:0001203311-21-000100:0·
€18,264129 shares@ €141.58120.3% of flow
Common Stock
SEC:0001203311-21-000074·
€18,264129 shares@ €141.58120.1% of flow
Common Stock
SEC:0001203311-21-000074:0·
€524,9453,701 shares@ €141.83879.0% of flow
Common Stock
SEC:0000899243-21-034988·
€524,9453,701 shares@ €141.83874.1% of flow
Common Stock
SEC:0000899243-21-034988:0·
€217,4001,657 shares@ €131.20093.7% of flow
Common Stock
SEC:0001203311-21-000062·
€217,4001,657 shares@ €131.20091.7% of flow
Common Stock
SEC:0001203311-21-000062:0·
€1m9,900 shares@ €133.415622.5% of flow
Common Stock
SEC:0001203311-21-000053·
€1m9,900 shares@ €133.415610.2% of flow
Common Stock
SEC:0001203311-21-000053:0·
€3m25,109 shares@ €126.894854.4% of flow
Common Stock
SEC:0001203311-21-000049·
€3m25,109 shares@ €126.894824.7% of flow
Common Stock
SEC:0001203311-21-000049:0·
19 of 19 declarations
About DANSEY ROGER D
Roger D Dansey is an executive at Seagen Inc.
